Mycodern S.A.
Mycodern S.A., a technology company, engages in the provision of solutions for the collection of libraries and archives, materials for forensics, production of graphic media, sale of exhibition systems, and development of machinery technology for production systems in Poland. The company offers graphic media, including media, laminates, glues, berger fabric, and laminotrs; and libraries, such as … Read more
Mycodern S.A. (GY3) - Net Assets
Latest net assets as of September 2025: €1.17 Million EUR
Based on the latest financial reports, Mycodern S.A. (GY3) has net assets worth €1.17 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.52 Million) and total liabilities (€3.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.17 Million |
| % of Total Assets | 25.85% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 47.64 |
Mycodern S.A. - Net Assets Trend (2021–2024)
This chart illustrates how Mycodern S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Mycodern S.A. (2021–2024)
The table below shows the annual net assets of Mycodern S.A. from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.22 Million | -95.54% |
| 2023-12-31 | €27.36 Million | -0.27% |
| 2022-12-31 | €27.44 Million | -- |
| 2021-12-31 | €0.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mycodern S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2752672859.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €33.84 Million | 2773.71% |
| Total Equity | €1.22 Million | 100.00% |
Mycodern S.A. Competitors by Market Cap
The table below lists competitors of Mycodern S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kadimastem Ltd
PINK:KMSTF
|
$6.11 Million |
|
Wellgistics Health, Inc. Common Stock
NASDAQ:WGRX
|
$6.11 Million |
|
Rohas Tecnic Bhd
KLSE:9741
|
$6.11 Million |
|
Dc Infotech And Communication Limited
NSE:DCI
|
$6.11 Million |
|
HF COMPANY INH. EO -50
F:HFC
|
$6.10 Million |
|
Inter-Rock Minerals Inc
PINK:IRCKF
|
$6.09 Million |
|
Enduro Metals Corporation
OTCQB:ENDMF
|
$6.09 Million |
|
Skycorp Solar Group Limited Ordinary Shares
NASDAQ:PN
|
$6.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mycodern S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 27,363,820 to 1,220,074, a change of -26,143,746 (-95.5%).
- Net loss of 27,396,548 reduced equity.
- Other factors increased equity by 1,252,803.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-27.40 Million | -2245.48% |
| Other Changes | €1.25 Million | +102.68% |
| Total Change | €- | -95.54% |
Book Value vs Market Value Analysis
This analysis compares Mycodern S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 10.19x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.00 | €0.19 | x |
| 2022-12-31 | €2.93 | €0.19 | x |
| 2023-12-31 | €0.41 | €0.19 | x |
| 2024-12-31 | €0.02 | €0.19 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mycodern S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2245.48%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1289.32%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 3.78x
- Recent ROE (-2245.48%) is below the historical average (-561.43%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | -48.94% | 0.00x | 0.00x | €-4.98 Million |
| 2022 | -0.21% | -11.11% | 0.02x | 1.01x | €-2.80 Million |
| 2023 | -0.03% | -0.98% | 0.03x | 1.15x | €-2.74 Million |
| 2024 | -2245.48% | -1289.32% | 0.46x | 3.78x | €-27.52 Million |
Industry Comparison
This section compares Mycodern S.A.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $2,832,678,733,200
- Average return on equity (ROE) among peers: 0.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mycodern S.A. (GY3) | €1.17 Million | 0.00% | 2.87x | $6.11 Million |
| COFCO Joycome Foods Limited (0M7) | $9.25 Billion | -0.10% | 0.76x | $482.93 Million |
| WH Group Ltd (0WH) | $9.69 Billion | 11.03% | 1.00x | $7.82 Billion |
| A2 Milk Company Ltd (14L) | $1.08 Billion | 7.44% | 0.27x | $4.22 Billion |
| HOCHDORF HLDG AG (1Z3) | $157.90 Million | -6.47% | 0.72x | $3.93 Million |
| PT Salim Ivomas Pratama Tbk (2IR) | $23.99 Trillion | 6.46% | 0.55x | $11.50 Million |
| DaChan Food (Asia) Limited (3DS) | $2.27 Billion | 6.85% | 0.52x | $17.89 Million |
| Global Sweeteners Holdings Limited (3GS) | $-218.25 Million | 0.00% | 0.00x | $2.66 Million |
| Meiji Holdings Co. Ltd (3M0) | $713.02 Billion | 12.27% | 0.57x | $5.87 Billion |
| Megmilk Snow Brand Co. Ltd (6MG) | $116.45 Billion | 2.21% | 1.87x | $839.43 Million |
| PT Eagle High Plantations Tbk (7B7) | $3.49 Trillion | -31.00% | 3.32x | $31.04 Million |